文献速递角膜与眼表疾病

2%瑞巴派特滴眼液对Sod1敲除小鼠结膜分化的作用

The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

研究在50周龄雄性Sod1-/-干眼小鼠模型和野生型小鼠中,给予2%瑞巴派特滴眼液每日四次持续2周,评估泪液分泌、泪膜破裂时间、活体染色及结膜分化标志物。结果显示Sod1-/-小鼠泪膜破裂时间和活体染色评分显著改善,角膜荧光素和玫瑰红染色评分显著降低,SPDEF表达显著增加而转谷氨酰胺酶-1和 involucrin 表达显著下降。作者认为局部使用2%瑞巴派特可改善Sod1-/-小鼠结膜上皮分化并抑制角化。

要点

  • 2%瑞巴派特滴眼液每日四次治疗2周后,Sod1-/-小鼠泪膜破裂时间显著改善(P=0.003)。
  • Sod1-/-小鼠角膜荧光素染色评分(P=0.0093)和玫瑰红染色评分(P=0.002)显著降低。
  • Sod1-/-小鼠结膜SPDEF mRNA显著增加(P=0.0003),转谷氨酰胺酶-1(P=0.0072)和 involucrin(P=0.009)mRNA显著下降。

核心结论

  • 局部使用2%瑞巴派特滴眼液可改善Sod1-/-小鼠结膜上皮分化并抑制角化。

研究设计与样本

  • 研究将2%瑞巴派特滴眼液每日四次滴入六只50周龄雄性Sod1-/-小鼠和六只C57BL/6野生型雄性小鼠,持续2周。

主要发现

  • 两种小鼠品系治疗后平均泪液量均无显著变化(P=0.24)。
  • Sod1-/-小鼠治疗后平均泪膜破裂时间(P=0.003)和活体染色评分显著改善。
  • 2%瑞巴派特治疗使Sod1-/-小鼠角膜荧光素染色评分显著降低(P=0.0093),玫瑰红染色评分显著降低(P=0.002)。
  • Sod1-/-小鼠治疗后免疫组化显示SPDEF染色明显增加,转谷氨酰胺酶-1和 involucrin 染色明显减少。
  • Sod1-/-小鼠治疗后SPDEF mRNA显著增加(P=0.0003),转谷氨酰胺酶-1 mRNA显著下降(P=0.0072), involucrin mRNA显著下降(P=0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The superoxide dismutase-1 knockout (Sod1-/-) mouse is an age-related dry eye mouse model. We evaluated the role of 2% rebamipide ophthalmic solution on the conjunctiva and ocular surface alterations in Sod1-/- mice. METHODS: Rebamipide eye drops (2%) were instilled in six 50-week-old male Sod1-/- mice and six C57BL/6 strain wild-type (WT) male mice four times a day for 2 weeks. Aqueous tear secretion quantity and tear film breakup time measurements as well as vital stainings were performed. Immunohistochemistry staining of the conjunctiva was performed using SAM pointed domain-containing ETS transcription factor (SPDEF), transglutaminase-1, and involucrin antibodies. Quantitative RT-PCR was carried out to study mRNA expression of the same markers. RESULTS: The mean tear quantities showed no significant changes in both mice strains after treatment (P = 0.24). The mean tear film breakup time (P = 0.003) and vital staining scores significantly improved in the Sod1-/- mice after treatment. Treatment with 2% rebamipide eye drops significantly decreased the corneal fluorescein (P = 0.0093) and Rose Bengal (P = 0.002) staining scores in the Sod1-/- mice. We showed a notable increase in SPDEF and a marked decrease in transglutaminase-1 and involucrin immunohistochemistry stainings, together with a significant increase in SPDEF (P = 0.0003) and a significant decline in transglutaminase-1 (P = 0.0072) and involucrin (P = 0.009) mRNA expression after treatment in the Sod1-/- mice. CONCLUSIONS: Topical use of 2% rebamipide drops was observed to improve conjunctival epithelial differentiation and suppress keratinization in the Sod1-/- mice.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kojima T, Simsek C, Igarashi A, et al. The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice. Invest Ophthalmol Vis Sci. 2018. PMID: 29625494. doi:10.1167/iovs.17-23213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。